MDGL - MADRIGAL PHARMACEUTICALS, INC.

QQQ $ 439.55 $ -0.26 (-0.06 %)

DIA $ 390.50 $ 1.74 (0.45 %)

SPY $ 517.10 $ 0.05 (0.01 %)

TLT $ 90.18 $ -0.55 (-0.61 %)

GLD $ 213.58 $ -0.63 (-0.29 %)

Previous Close

$ 208.04

Open

$ 211.79

Bid

$ 0.00 x 0

Ask

$ 208.74 x 100

Day's Range

$ 202.01 - $ 211.79

52 Week Range

$ 119.76 - $ 311.56

Volume

690,457

Average Volume

Market Cap

4.16B

Beta (5Y Monthly)

$ 0.75

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-07-2024	03-31-2024	10-Q
2	02-28-2024	12-31-2023	10-K
3	11-06-2023	09-30-2023	10-Q
4	08-08-2023	06-30-2023	10-Q
5	05-09-2023	03-31-2023	10-Q
6	02-23-2023	12-31-2022	10-K
7	11-03-2022	09-30-2022	10-Q
8	08-04-2022	06-30-2022	10-Q
9	05-09-2022	03-31-2022	10-Q
10	02-24-2022	12-31-2021	10-K
11	11-04-2021	09-30-2021	10-Q
12	08-05-2021	06-30-2021	10-Q
13	05-06-2021	03-31-2021	10-Q
14	02-25-2021	12-31-2020	10-K
15	11-05-2020	09-30-2020	10-Q
16	08-06-2020	06-30-2020	10-Q
17	05-07-2020	03-31-2020	10-Q
18	02-26-2020	12-31-2019	10-K
19	11-06-2019	09-30-2019	10-Q
20	08-07-2019	06-30-2019	10-Q
21	05-08-2019	03-31-2019	10-Q
22	02-27-2019	12-31-2018	10-K
23	11-06-2018	09-30-2018	10-Q
24	08-07-2018	06-30-2018	10-Q
25	05-08-2018	03-31-2018	10-Q
26	03-13-2018	12-31-2017	10-K
27	11-09-2017	09-30-2017	10-Q
28	08-10-2017	06-30-2017	10-Q
29	05-11-2017	03-31-2017	10-Q
30	03-31-2017	12-31-2016	10-K
31	11-14-2016	09-30-2016	10-Q
32	07-20-2016	06-30-2016	10-Q
33	05-10-2016	03-31-2016	10-Q
34	03-15-2016	12-31-2015	10-K
35	11-05-2015	09-30-2015	10-Q
36	08-06-2015	06-30-2015	10-Q
37	05-07-2015	03-31-2015	10-Q
38	03-12-2015	12-31-2014	10-K
39	11-06-2014	09-30-2014	10-Q
40	08-06-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Maintains Buy on Madri...
05/08/2024 19:32:37

HC Wainwright & Co. analyst Ed Arce maintains Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Buy and lowers the price tar...

Citigroup Maintains Buy on Madrigal Pharma...
05/08/2024 19:16:52

Citigroup analyst David Lebovitz maintains Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Buy and lowers the price target fro...

JMP Securities Maintains Market Outperform...
05/08/2024 18:00:54

JMP Securities analyst Jonathan Wolleben maintains Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Market Outperform and lower...

12-health-care-stocks-moving-in-tuesdays-pre-market-session

12 Health Care Stocks Moving In Tuesday's ...
05/07/2024 12:06:20

Madrigal Pharmaceuticals Q1 2024 GAAP EPS ...
05/07/2024 11:21:41

Madrigal Pharmaceuticals (NASDAQ:MDGL) reported quarterly losses of $(7.38) per share which missed the analyst consensus estima...

10-health-care-stocks-whale-activity-in-todays-session

10 Health Care Stocks Whale Activity In To...
05/03/2024 17:35:23

B of A Securities Initiates Coverage On Ma...
04/22/2024 10:19:38

B of A Securities analyst Alexandria Hammond initiates coverage on Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Underperfor...

Evercore ISI Group Maintains Outperform on...
03/20/2024 15:26:06

Evercore ISI Group analyst Liisa Bayko maintains Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Outperform and raises the pri...

Madrigal Pharmaceuticals Prices Upsized $6...
03/19/2024 06:13:31

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for nonalco...

Madrigal Pharmaceuticals Announces Propose...
03/18/2024 20:05:18

10 Health Care Stocks Whale Activity In To...
03/18/2024 17:35:23

Why Jabil Shares Are Trading Lower By Over...
03/15/2024 18:31:53

Shares of Jabil Inc. (NYSE: JBL) fell sharply during Friday’s session after the company reported financial second-quarter resu...

UBS Maintains Buy on Madrigal Pharmaceutic...
03/15/2024 17:13:47

UBS analyst Eliana Merle maintains Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Buy and raises the price target from $337 t...

TD Cowen Maintains Outperform on Madrigal ...
03/15/2024 16:44:03

TD Cowen analyst Ritu Baral maintains Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Outperform and raises the price target f...

fda-conditionally-approves-madrigal-pharmaceuticals-resmetirom-as-first-treatment-for-fatty-liver-disease-with-scarring

FDA Conditionally Approves Madrigal Pharma...
03/15/2024 15:32:25

FDA's accelerated approval for Madrigal Pharmaceuticals' Rezdiffra for noncirrhotic nonalcoholic steatohepatitis with l...

Citigroup Maintains Buy on Madrigal Pharma...
03/15/2024 15:10:56

Citigroup analyst David Lebovitz maintains Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Buy and raises the price target fro...

blend-labs-reports-q4-results-joins-alta-equipment-despegarcom-and-other-big-stocks-moving-higher-on-friday

Blend Labs Reports Q4 Results, Joins Alta ...
03/15/2024 14:25:26

U.S. stocks were lower, with the Dow Jones index falling around 100 points on Friday. Shares of Blend Labs, Inc. (NASDAQ: BLN...

12-health-care-stocks-moving-in-fridays-pre-market-session

12 Health Care Stocks Moving In Friday's P...
03/15/2024 13:06:20

Market-Moving News for March 15th
03/15/2024 12:36:47

MDGL: 28% | Madrigal Pharmaceuticals shares are trading higher after the company announced FDA approval of Rezdiffra for the tr...

Oppenheimer Maintains Outperform on Madrig...
03/15/2024 12:27:23

Oppenheimer analyst Jay Olson maintains Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Outperform and raises the price target...